Ownership Don’t Lie: Institutional Investors Positive on Cyanotech Corp (NASDAQ:CYAN)

November 21, 2016 - By kentuckypostne   ·   0 Comments

Ownership Don't Lie: Institutional Investors  Positive on Cyanotech Corp (NASDAQ:CYAN)

Sentiment for Cyanotech Corp (NASDAQ:CYAN)

Cyanotech Corp (NASDAQ:CYAN) institutional sentiment increased to 6 in Q2 2016. Its up 4.00, from 2 in 2016Q1. The ratio is positive, as 4 investment professionals started new or increased holdings, while 2 trimmed and sold stock positions in Cyanotech Corp. The investment professionals in our partner’s database now possess: 1.13 million shares, up from 1.12 million shares in 2016Q1. Also, the number of investment professionals holding Cyanotech Corp in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 1 Reduced: 1 Increased: 3 New Position: 1.

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company has a market cap of $23.08 million. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. It currently has negative earnings. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

About 397 shares traded hands. CYANOTECH CORP (NASDAQ:CYAN) has declined 17.60% since April 19, 2016 and is downtrending. It has underperformed by 21.46% the S&P500.

According to Zacks Investment Research, “CYANOTECH CORP. develops and commercializes natural products from microalgae. Co. is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets and is also developing microalgae-based products for the aquaculture feed/pigments, biopesticide and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients.”

Coastline Trust Co holds 0.09% of its portfolio in CYANOTECH CORP for 82,400 shares. Salem Investment Counselors Inc owns 15,178 shares or 0.01% of their US portfolio. Moreover, Blackrock Fund Advisors has 0% invested in the company for 755 shares. The California-based Blackrock Institutional Trust Company N.A. has invested 0% in the stock. California Public Employees Retirement System, a California-based fund reported 19,300 shares.#img1#

CYAN Company Profile

Cyanotech Corporation, incorporated on March 3, 1980, is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids. Hawaiian BioAstin is a dietary antioxidant shown to support and maintain the body’s natural inflammatory response, to enhance skin, and to support eye and joint health. The Firm cultivates over two microalgal species from which its product lines, natural astaxanthin products and spirulina products, are derived.

More notable recent CYANOTECH CORP (NASDAQ:CYAN) news were published by: Streetinsider.com which released: “Meridian OHC Partners Changes Filing Status on Cyanotech Corp (CYAN) from …” on May 09, 2016, also Bizjournals.com with their article: “Hawaii-based Cyanotech Corp. embroiled in legal case involving shareholder” published on May 27, 2016, Bizjournals.com published: “Kailua-Kona-based Cyanotech reports second-quarter financials” on November 12, 2016. More interesting news about CYANOTECH CORP (NASDAQ:CYAN) were released by: Bizjournals.com and their article: “Cyanotech CEO resigns, founder steps in for the interim” published on April 04, 2016 as well as Businesswire.com‘s news article titled: “Cyanotech® Corporation Earns Non-GMO Project Verification for BULK SCE …” with publication date: September 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By kentuckypostne


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>